The therapeutic potential of the Wnt signaling pathway in bone disorders.
暂无分享,去创建一个
T. He | Q. Shi | Liang Chen | Yang Bi | H. Luu | Z. Deng | Jinyong Luo | Xiaoji Luo | R. Reid | R. Haydon | Jian-Li Gao | Stephanie H Kim | G. Zuo | Bai-Cheng He | Qing Luo | Yanhong Gao | Bing-qiang Zhang | E. Wagner | Ke-Qin Yang | Yuxi Su | Jiayi Huang | F. Rastegar | Enyi Huang | G. Zhu | Keqin Yang | Eric R. Wagner | Gao-hui Zhu
[1] D. Carson,et al. Repression of beta-catenin signaling by PPAR gamma ligands. , 2010, European journal of pharmacology.
[2] T. P. Rao,et al. An updated overview on Wnt signaling pathways: a prelude for more. , 2010, Circulation research.
[3] J. Puzas,et al. Axin2 controls bone remodeling through the β-catenin–BMP signaling pathway in adult mice , 2009, Journal of Cell Science.
[4] Guoyin Feng,et al. Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β‐Catenin Signaling , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] K. Chihara,et al. Role of Smad3, acting independently of transforming growth factor‐β, in the early induction of Wnt‐β‐catenin signaling by parathyroid hormone in mouse osteoblastic cells , 2009, Journal of cellular biochemistry.
[6] Qing-yang Huang,et al. The -9247 T/C polymorphism in the SOST upstream regulatory region that potentially affects C/EBPalpha and FOXA1 binding is associated with osteoporosis. , 2009, Bone.
[7] T. He,et al. BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling , 2009, Journal of cellular and molecular medicine.
[8] Debbie Y. Dao,et al. Axin2 regulates chondrocyte maturation and axial skeletal development , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[9] Ichiro Takada,et al. Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis , 2009, Nature Reviews Rheumatology.
[10] B. Komm,et al. A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation. , 2009, Bone.
[11] Lance E. Lanyon,et al. The mouse fibula as a suitable bone for the study of functional adaptation to mechanical loading , 2009, Bone.
[12] David M. Thomas,et al. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. , 2009, The Journal of clinical investigation.
[13] K. Ozono,et al. Wnt signaling in bone metabolism , 2009, Journal of Bone and Mineral Metabolism.
[14] Benjamin A Alman,et al. Wnt pathway, an essential role in bone regeneration , 2009, Journal of cellular biochemistry.
[15] B. Williams,et al. Where Wnts Went: The Exploding Field of Lrp5 and Lrp6 Signaling in Bone , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] A. Montag,et al. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects , 2008, Laboratory Investigation.
[17] M. Bouxsein,et al. Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes , 2008, PloS one.
[18] T. He,et al. Osteosarcoma Development and Stem Cell Differentiation , 2008, Clinical orthopaedics and related research.
[19] P. Kostenuik,et al. Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] W. Van Hul,et al. Wnt signaling: a win for bone. , 2008, Archives of biochemistry and biophysics.
[21] T. Day,et al. Wnt and hedgehog signaling pathways in bone development. , 2008, The Journal of bone and joint surgery. American volume.
[22] David J J de Gorter,et al. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. , 2008, The Journal of bone and joint surgery. American volume.
[23] S. Kakar,et al. Enhanced Chondrogenesis and Wnt Signaling in PTH‐Treated Fractures , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] Kunihiro Matsumoto,et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivation , 2007, Nature Cell Biology.
[25] Kozo Nakamura,et al. GSK-3β Controls Osteogenesis through Regulating Runx2 Activity , 2007, PloS one.
[26] B. Alman,et al. Beta-Catenin Signaling Plays a Disparate Role in Different Phases of Fracture Repair: Implications for Therapy to Improve Bone Healing , 2007, PLoS medicine.
[27] G. Karsenty,et al. In vivo analysis of Wnt signaling in bone. , 2007, Endocrinology.
[28] I. Gérin,et al. Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein α and Peroxisome Proliferator-activated Receptor γ* , 2007, Journal of Biological Chemistry.
[29] A. Montag,et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[30] R. Moon,et al. Chibby Promotes Adipocyte Differentiation through Inhibition of β-Catenin Signaling , 2007, Molecular and Cellular Biology.
[31] Jayaram Radhakrishnan,et al. LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors , 2007, Science.
[32] T. He,et al. Wnt signaling and human diseases: what are the therapeutic implications? , 2007, Laboratory Investigation.
[33] R. Marcus,et al. Osteosarcoma and Teriparatide? , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] P. Kostenuik,et al. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. , 2006, Bone.
[35] A. McMahon,et al. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors , 2006, Development.
[36] R. Baron,et al. Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] T. Engler,et al. Orally Bioavailable GSK‐3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo , 2006 .
[38] O. MacDougald,et al. Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.
[39] Ian Smyth,et al. Human sebaceous tumors harbor inactivating mutations in LEF1 , 2006, Nature Medicine.
[40] C. Hartmann. A Wnt canon orchestrating osteoblastogenesis. , 2006, Trends in cell biology.
[41] S. O’Rahilly,et al. WNT10B mutations in human obesity , 2006, Diabetologia.
[42] M. Almeida,et al. Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by β-Catenin-dependent and -independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT* , 2005, Journal of Biological Chemistry.
[43] R. Baron,et al. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Jilka,et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. , 2005, Endocrinology.
[45] M. Karperien,et al. Downregulation of Wnt Signaling by Increased Expression of Dickkopf‐1 and ‐2 is a Prerequisite for Late‐Stage Osteoblast Differentiation of KS483 Cells , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] T. He. Distinct osteogenic activity of BMPs and their orthopaedic applications. , 2005, Journal of musculoskeletal & neuronal interactions.
[47] Sophie Janssens,et al. Transforming Growth Factor- 1 to the Bone , 2005 .
[48] Caiying Guo,et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation , 2005, Nature Genetics.
[49] Xi He,et al. SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor* , 2005, Journal of Biological Chemistry.
[50] P. Vestergaard,et al. Reduced Relative Risk of Fractures Among Users of Lithium , 2005, Calcified Tissue International.
[51] Hans Clevers,et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.
[52] Bart O. Williams,et al. Essential Role of β-Catenin in Postnatal Bone Acquisition* , 2005, Journal of Biological Chemistry.
[53] P. ten Dijke,et al. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. , 2005, Cytokine & growth factor reviews.
[54] Peng Liu,et al. Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling* , 2005, Journal of Biological Chemistry.
[55] Hans Clevers,et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. , 2005, Developmental cell.
[56] W. Birchmeier,et al. The role of Axin2 in calvarial morphogenesis and craniosynostosis , 2005, Development.
[57] H. Clevers,et al. Wnt signalling in stem cells and cancer , 2005, Nature.
[58] Chul-hak Yang,et al. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. , 2005, Biochemical and biophysical research communications.
[59] M. Bouxsein,et al. Decreased BMD and Limb Deformities in Mice Carrying Mutations in Both Lrp5 and Lrp6 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[60] Wei Jiang,et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. , 2004, Current cancer drug targets.
[61] Matthias B. Wahl,et al. Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis , 2004, Development.
[62] J. Westendorf,et al. Wnt signaling in osteoblasts and bone diseases. , 2004, Gene.
[63] Laurie E Ailles,et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.
[64] L. Southam,et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[65] G. Sandusky,et al. Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose , 2004, Toxicologic pathology.
[66] A. Tarnawski,et al. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. , 2004, Molecular biology of the cell.
[67] I. Thesleff,et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. , 2004, American journal of human genetics.
[68] Gary S Stein,et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. , 2004, Molecular endocrinology.
[69] M. Ascano,et al. Regulation of Hedgehog signaling: a complex story. , 2004, Biochemical pharmacology.
[70] P. Roberson,et al. Proteasomal Degradation of Runx2 Shortens Parathyroid Hormone-induced Anti-apoptotic Signaling in Osteoblasts , 2003, Journal of Biological Chemistry.
[71] E. Canalis,et al. Notch 1 impairs osteoblastic cell differentiation. , 2003, Endocrinology.
[72] E. Olson,et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth , 2003, Development.
[73] J. A. Robinson,et al. High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[74] E. Fuchs,et al. Stem cells in the skin: waste not, Wnt not. , 2003, Genes & development.
[75] J. Szatkowski,et al. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. , 2003, Cancer letters.
[76] Richard W. Carthew,et al. Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway , 2003, Nature.
[77] Xi He,et al. Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. , 2003, Genes & development.
[78] Masato Nose,et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[79] A. Montag,et al. Cytoplasmic and/or nuclear accumulation of the β‐catenin protein is a frequent event in human osteosarcoma , 2002, International journal of cancer.
[80] G. Boland,et al. Wnt-3A Enhances Bone Morphogenetic Protein-2-mediated Chondrogenesis of Murine C3H10T1/2 Mesenchymal Cells* , 2002, The Journal of Biological Chemistry.
[81] Richard P Lifton,et al. High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.
[82] Ivan Lobov,et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.
[83] Miikka Vikkula,et al. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.
[84] J. Bilezikian. Anabolic Therapy for Osteoporosis , 2005, Women's health.
[85] M Dioszegi,et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). , 2001, Human molecular genetics.
[86] D. Galas,et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. , 2001, American journal of human genetics.
[87] R. Davis,et al. Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.
[88] William C. Skarnes,et al. An LDL-receptor-related protein mediates Wnt signalling in mice , 2000, Nature.
[89] C. Hartmann,et al. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. , 2000, Development.
[90] G. Cossu,et al. Wnt signaling and the activation of myogenesis in mammals , 1999, The EMBO journal.
[91] K. Kinzler,et al. PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.
[92] A. McMahon,et al. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. , 1999, Genes & development.
[93] T. Komori,et al. Cbfa1 Isoforms Exert Functional Differences in Osteoblast Differentiation* , 1999, The Journal of Biological Chemistry.
[94] Hans Clevers,et al. Drosophila Tcf and Groucho interact to repress Wingless signalling activity , 1998, Nature.
[95] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[96] Hans Clevers,et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 , 1998, Nature Genetics.
[97] S. Tonegawa,et al. Skeletal and CNS Defects in Presenilin-1-Deficient Mice , 1997, Cell.
[98] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[99] Jeremy Nathans,et al. A new member of the frizzled family from Drosophila functions as a Wingless receptor , 1996, Nature.
[100] R. Moon,et al. Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development , 1996, The Journal of cell biology.
[101] I Fariñas,et al. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. , 1994, Genes & development.
[102] F. Masiarz,et al. Association of the APC gene product with beta-catenin. , 1993, Science.
[103] K. Kinzler,et al. Association of the APC tumor suppressor protein with catenins. , 1993, Science.
[104] R. Lindsay,et al. Anabolic actions of parathyroid hormone on bone. , 1993, Endocrine reviews.
[105] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[106] C. Deal. Potential new drug targets for osteoporosis , 2009, Nature Clinical Practice Rheumatology.
[107] A. McMahon,et al. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. , 2007, Developmental cell.
[108] H. Clevers. Wnt/beta-catenin signaling in development and disease. , 2006, Cell.
[109] T. Martin,et al. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[110] M. Bouxsein,et al. Essential role of beta-catenin in postnatal bone acquisition. , 2005, The Journal of biological chemistry.
[111] P. Greengard,et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.
[112] Frank Petersen,et al. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. , 2004, Cancer cell.
[113] T. Ishida,et al. Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis , 2004, Clinical & Experimental Metastasis.
[114] M. Kühl. The WNT/calcium pathway: biochemical mediators, tools and future requirements. , 2004, Frontiers in bioscience : a journal and virtual library.
[115] J. Kitagaki,et al. Activation of beta-catenin-LEF/TCF signal pathway in chondrocytes stimulates ectopic endochondral ossification. , 2003, Osteoarthritis and cartilage.
[116] R. Moon,et al. Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway. , 2003, Nature.
[117] J. Bilezikian,et al. Clinical review 123: Anabolic therapy for osteoporosis. , 2001, The Journal of clinical endocrinology and metabolism.
[118] F. McCormick,et al. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.
[119] K. Kinzler,et al. PPAR d Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999 .
[120] E. Fuchs,et al. A common human skin tumour is caused by activating mutations in beta-catenin. , 1999, Nature genetics.
[121] D. J. Van Den Berg,et al. Role of members of the Wnt gene family in human hematopoiesis. , 1998, Blood.
[122] H Clevers,et al. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. , 1998, Immunity.
[123] R. Nusse,et al. Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.